These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36059975)

  • 1. Case report: Kinetics of human leukocyte antigen receptor HLA-DR during liver injury induced by potassium para-aminobenzoate as assessed for causality using the updated RUCAM.
    Plüß M; Tampe D; Schwörer H; Bremer SCB; Tampe B
    Front Pharmacol; 2022; 13():966910. PubMed ID: 36059975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM).
    Teschke R; Danan G
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33800917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overview.
    Teschke R; Eickhoff A; Schulze J; Danan G
    Transl Gastroenterol Hepatol; 2021; 6():51. PubMed ID: 34423172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations.
    Teschke R
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
    Danan G; Teschke R
    Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis.
    Teschke R; Danan G
    Medicines (Basel); 2020 Sep; 7(10):. PubMed ID: 33003400
    [No Abstract]   [Full Text] [Related]  

  • 7. Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature.
    Abeles RD; Foxton M; Khan S; Goldin R; Smith B; Thursz MR; Verma S
    BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33214235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM).
    Shumar J; Ordway S; Junga Z; Sadowski B; Torres D
    ACG Case Rep J; 2019 Aug; 6(8):e00184. PubMed ID: 31737715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019.
    Teschke R
    Front Pharmacol; 2019; 10():730. PubMed ID: 31396080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study.
    Rodríguez A; García-García I; Martínez de Soto L; Gómez López De Las Huertas A; Borobia AM; González-Torbay A; Akatbach-Bousaid I; González-Muñoz M; Ramírez E
    Front Pharmacol; 2022; 13():819589. PubMed ID: 35370653
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute hepatitis associated with treatment of Peyronie's disease with potassium para-aminobenzoate (Potaba).
    Roy J; Carrier S
    J Sex Med; 2008 Dec; 5(12):2967-9. PubMed ID: 18624965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
    Teschke R; Schulze J; Eickhoff A; Danan G
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future.
    Danan G; Teschke R
    Front Pharmacol; 2019; 10():853. PubMed ID: 31417407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment Method.
    Ye L; Feng Z; Huang L; Guo C; Wu X; He L; Tan W; Wang Y; Wu X; Hu B; Li T; Yang G; Chengxian G; He Q
    Front Pharmacol; 2021; 12():790108. PubMed ID: 34987403
    [No Abstract]   [Full Text] [Related]  

  • 15. A case report of a drug-induced liver injury (DILI) caused by multiple antidepressants with causality established by the updated Roussel Uclaf causality assessment method (RUCAM) and in vitro testing.
    González-Muñoz M; Monserrat Villatoro J; Marín-Serrano E; Stewart S; Bardón Rivera B; Marín J; Martínez de Soto L; Seco Meseguer E; Ramírez E
    Clin Case Rep; 2020 Dec; 8(12):3105-3109. PubMed ID: 33363890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUCAM in Drug and Herb Induced Liver Injury: The Update.
    Danan G; Teschke R
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
    Teschke R
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM.
    Shi X; Zuo C; Yu L; Lao D; Li X; Xu Q; Lv Q
    Front Pharmacol; 2021; 12():761167. PubMed ID: 34795591
    [No Abstract]   [Full Text] [Related]  

  • 19. Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.
    Danjuma MI; Almasri H; Alshokri S; Khir FK; Elmalik A; Battikh NG; Abdallah IMH; Elshafei M; Fatima H; Mohamed MFH; Maghoub Y; Hussain T; Kamal I; Anwer Z; Bidmos MA; Elzouki AN
    BMC Geriatr; 2020 Sep; 20(1):346. PubMed ID: 32928134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature.
    Studentova H; Volakova J; Spisarova M; Zemankova A; Aiglova K; Szotkowski T; Melichar B
    BMC Gastroenterol; 2022 Feb; 22(1):49. PubMed ID: 35123392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.